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Abstract
Human leprosy is primarily caused by Mycobacterium leprae, but also by the related 
‘M.  lepromatosis’. Ancient leprosy can be recognised in archaeological materials by the 
paleopathology associated with multi-bacillary or lepromatous forms of the disease. Whole 
M. leprae genomes have been obtained from human skeletons, and diagnostic aDNA frag-
ments have been recovered. The derived M. leprae phylogenies, based on single nucleotide 
polymorphisms, mirror past human migrations, as M. leprae is usually an obligate pathogen. 
The detection of M. leprae in historical leprosy cases is assisted by the hydrophobic M. leprae 
cell envelope, which is composed of unusual lipids that can be used as specific biomarkers. 
Lipid biomarkers are more stable than aDNA and can be detected directly without amplifi-
cation. Indigenous human leprosy is extinct in Western Europe, but recently, both M. leprae 
and ‘M. lepromatosis’ were found in British red squirrels. Leprosy may also be found in nine-
banded armadillos (Dasypus  novemcinctus) where it can cause a zoonotic human infection. 
Certain leprosy-like diseases, caused by uncultivable species in cats, for example, may be 
related to M. leprae. The closest extant relatives of leprosy bacilli are probably members of the 
M.  haemophilum taxon, emerging pathogens with genomic and lipid biomarker similarities.
Keywords: ancient DNA, lipid biomarkers, genotyping, leprosy, paleopathology, 
evolution
1. Introduction
Leprosy (Hansen’s disease) is a chronic infectious disease that has been recognised over mil-
lennia. In the majority of human cases, it is caused by Mycobacterium leprae, but recently a 
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related organism, ‘M. lepromatosis’, has also been implicated [1] and appears to cause diffuse 
lepromatous leprosy (DLL). Both organisms are obligate pathogens that are uncultivable in 
cell-free growth media. Although ‘M. lepromatosis’ has been the subject of many recent publi-
cations [2–5], there is still discussion about whether it is a distinct species [6]; currently, it is 
a name without standing in nomenclature (http://www.bacterio.net/-nonvalid.html). Leprosy 
is primarily a disease of peripheral nerves and skin, but it also affects bones. The genomes of 
M. leprae and ‘M. lepromatosis’ have been sequenced, and it is clear that they diverged from a 
common ancestor many millennia ago [7, 8]. The genome of ‘M. lepromatosis’ confirms a close 
but distinct relationship with M. leprae, and both organisms can also cause disease in animals, 
such as armadillos and squirrels [9–12]. The closest ancestors of these leprosy bacilli are prob-
ably relatives of M. haemophilum that has genomic and lipid biomarker similarities [13–16].
Initially, ancient leprosy was recognised by the paleopathology associated with multi-bacillary 
or lepromatous forms of the disease [17, 18]. Leprosy causes skeletal changes in the rhino-
maxillary area, including pitting and perforation in the palate, resorption of the nasal spine 
and the maxilla leading to loss of the upper teeth. The tubular bones of the hands and feet are 
frequently involved. In the tibia and fibula, inflammatory periostitis can be recognised; the 
metatarsals and metacarpals are often resorbed so these small bones develop a pencil shape. 
In sub-adult individuals afflicted with multibacillary leprosy, the development of the second-
ary dentition can be affected, leading to a rare condition, leprogenic odontodysplasia (LO), where 
the incisor teeth exhibit a characteristic root constriction [19]. Intriguingly, this has been seen 
only in archaeological cases and not in a clinical setting. Cases have been described from medi-
eval Denmark [20] and in four individual medieval inhumations from the St. Mary Magdalen, 
Winchester leprosarium [21]. Subtle skeletal changes like grooving on the volar surfaces of the 
proximal phalanges may also accompany paucibacillary forms of leprosy that cause digital 
contracture or loss of pain sensation [22].
Suspected leprosy cases can be confirmed by the detection of M. leprae ancient DNA (aDNA) 
[23, 24] and further characterised by repetitive DNA sequences and genotyping [25, 26]. The 
aDNA detection of M. leprae in historical cases is probably assisted by the protective presence 
of unusual lipids in the M. leprae cell envelope. These lipids can be used as specific biomark-
ers; they are more stable than aDNA and can be directly detected without amplification (vide 
infra). Lipid biomarkers have been used to confirm aDNA findings [21, 27–29]. However, due 
to their stability, lipid biomarkers can also confirm a diagnosis of leprosy initially based on 
paleopathology, even in the absence of aDNA [30].
2. Causes and distribution of modern leprosy
2.1. Mycobacterium leprae
M. leprae, the main cause of leprosy in humans, is a slow-growing intracellular Mycobacterium 
and the average incubation period of the disease is about 5 years, although symptoms may occur 
within 1 year or up to 20 years after infection [31]. Leprosy mainly affects the skin, peripheral 
nerves, the mucosa of the upper respiratory tract and the eyes, as M. leprae has a tropism for 
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Schwann cells in nerves and macrophages in the skin [32]. The infection is transmitted by direct 
contact with untreated cases or healthy carriers or via infectious aerosols [33]. The clinical presen-
tation of leprosy depends upon the cell-mediated immune (CMI) response to infection. If the host 
has an effective CMI response, few lesions develop, and there are only scanty bacilli in the tissues. 
However, some patients are anergic to M. leprae, so develop lepromatous leprosy with ineffective 
antibodies, a high bacterial load and multiple lesions. The clinical presentation of leprosy in a 
patient can vary over time, so there are borderline leprosy types where the immune response is 
unstable. It can show a wide range of clinical presentations from tuberculoid leprosy (TT) through 
borderline forms: borderline tuberculoid (BT), borderline borderline (BB), borderline leproma-
tous (BL) to lepromatous leprosy (LL) [34]. A recent World Health Organization classification 
scheme recognises a simplified two-category system of either paucibacillary or multibacillary 
forms of leprosy [35]. The histopathology of skin lesions varies from compact granulomas to dif-
fuse infiltration of dermis, which largely depend upon the immune status of the patient and may 
not be in agreement with the clinical diagnosis [36, 37]. The mycobacterial antigens can activate a 
chronic inflammatory response that is exacerbated by pro-inflammatory cytokines. Therefore, in 
late stages of leprosy, there may be no M. leprae bacilli in the tissues, but residual mycobacterial 
antigens can drive an inflammatory response that causes neurological damage [38].
2.2. ‘Mycobacterium lepromatosis’
‘M. lepromatosis’ appears to have a tropism for endothelial cells and can give rise to vasculitis 
and necrotic erythema. It seems to be less common than M. leprae and was initially believed 
to be geographically restricted to patients from Mexico and the Caribbean, where it was iden-
tified in patients suffering from diffuse lepromatous leprosy (DLL) [1, 39–41]. It was subse-
quently recognised in Brazil, Myanmar, Canada and Singapore and in mixed infections with 
M. leprae [3, 4]. Symptoms, characteristic of ‘Lucio’s phenomenon’, have been associated with 
‘M. lepromatosis’ [1, 40, 42]. A case of two Mexican siblings infected with ‘M. lepromatosis’ indi-
cates facile transmission [5, 6]. However, ‘M. lepromatosis’ has recently been found in the wild 
Eurasian red squirrel, Sciurus vulgaris, in the British Isles, from England, Scotland and Wales 
[11, 12]. In addition, M. leprae was found in red squirrels on the Isle of Wight and Brownsea 
Island, close to the south coast of England [43, 44]. This was very surprising, as although 
indigenous leprosy was prevalent in the human population of the British Isles in the first 
millennium (CE), it is now believed to be extinct. In these modern squirrels, the macroscopic 
signs and histopathology were characteristic of lepromatous leprosy, but no pathological dif-
ferences were noted between infections caused by ‘M. lepromatosis’ or M. leprae [12, 45]. The 
strain of ‘M. lepromatosis’ in British wild squirrels is genetically distinguishable from Mexican 
strains found in modern day humans, and it appears that these strains diverged from a com-
mon ancestor about 26,000 years ago [12]. However, the M. leprae strain found in British red 
squirrels is similar to a strain found in human remains from a mediaeval leprosy hospital in 
Winchester [46], only 70 km from the Isle of Wight and Brownsea Island. One suggestion is 
that, in the past, humans may have been infected through direct contact with red squirrels as 
these were prized for their meat and fur [12]. They were also kept as pets, as is evident from 
various illustrated medieval manuscripts and art, for example ‘A Lady with a Squirrel and a 
Starling’ by Holbein the Younger (painted ca. 1526–1528, National Portrait Gallery, London).
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2.3. Nature and distribution of M. leprae genotypes
Major collaborative studies based on single nucleotide polymorphism (SNP) typing have 
established that modern M. leprae consists of four distinct genotypes that are associated with 
different human populations [47]. It is believed that the ancestral precursor of M. leprae experi-
enced an evolutionary bottleneck and thereafter developed independently in different human 
populations [26, 48]. In Europe, indigenous leprosy is now largely extinct, so a further study 
also looked at M. leprae from archaeological cases using aDNA methods [26]. This identified 
SNP type 3 cases from various European countries for the first time, including Denmark, 
Hungary, Croatia, Turkey and Britain. Some cases provided subtypes I, M or K. Genotype 
3 strains were also found from Roman Egypt and by others in medieval Central Europe [30, 
49]. Later studies also reported SNP type 2 strains for the first time in medieval cases from 
Winchester, UK [21] and from Sweden [50, 51]. Archaeological remains from Japan yielded a 
SNP type 1 from that country [52]. Several of the robust cases were subsequently amplified by 
whole genome sequencing (WGS) [46, 53].
Monot et al. [26] also recognised sub-genotypes from extant cases, thereby enabling more 
precise associations between M. leprae, geographical location and present human populations 
ranging from China [54] to South America [55]. In a detailed study of modern M. leprae that 
included SNP typing, variable-number-tandem-repeat (VNTR) analysis and WGS, Truman 
et al. [9] examined 50 patients with leprosy and 33 wild armadillos (Dasypus novemcinctus) in 
the United States, together with reference strains from other parts of the world. Seven M. leprae 
SNP types were detected. The SNP type for some patients with possible exposure by foreign 
residence was typical of M. leprae from foreign locations. The most abundant SNP type was 
3I that is generally associated with historical northwest European or American populations. 
The SNP sub-type 3I-1 strains, with one copy of an 11-bp indel (indel_17915) had ancestral 
bases, but all other M. leprae strains have two copies. Type 3I-2 strains, a development of the 
ancestral 3I-1 strains, similarly have only one copy of indel ML_17915 and can be identified by 
base C at position 1527056 instead of base G present in type 3I-1 isolates [9]. These 3I-2 strains 
were found in all armadillos and most of the indigenous patients so the authors concluded 
that armadillos act as a reservoir for M. leprae and that there is zoonotic spread of leprosy in 
the Southern United States. As the disease was not present in the New World before European 
contact, it is assumed that the spread of the disease was linked to human migrations and that 
armadillos acquired leprosy from human cases [45, 56].
2.4. Transmission of leprosy
Recently it was realised that the enhanced hydrophobicity of tubercle bacilli is a key factor in 
aerosol transmission [57, 58]. Since it is becoming established that aerosol transmission is a 
prime mode for the spread of leprosy bacilli [33, 59], the transmissibility of the different mani-
festations of M. leprae should be considered. In a detailed study [33], it was demonstrated that 
MB/LL cases provided more transmissible bacilli than PB/TT patients. It would be of great 
interest to compare the relative cell envelope surface lipid composition of LL and TT leprosy 
bacilli to explore the possibility that the hydrophobicity of LL forms is enhanced or otherwise. 
It may also be possible to determine directly the relative hydrophobicity of M. leprae in biopsy 
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material, using micro fluorescence methods [60]. The evasion of airways epithelial clearance 
[33, 59] may be encouraged by enhanced hydrophobicity of infective agents.
3. Recognition, diagnosis and spread of ancient leprosy
3.1. Pathology and recognition of ancient leprosy
Leprosy is primarily a disease of the peripheral nervous system. In the past, the disease would 
run its natural course, resulting in both specific and nonspecific bony changes plus paleopa-
thology due to secondary infections following nerve damage [17, 18, 61]. Ancient leprosy is 
typically recognised by the presentation known as facies leprosa or rhinomaxillary syndrome, 
in which the nasopharynx is remodelled, the nasal spine and palate are resorbed, and eventu-
ally also the maxilla, leading to loss of the upper teeth. There are changes to the tubular bones 
of the hands and feet including osteoporosis caused by disuse, pitting and perforation. The 
long bones of the lower leg also show paleopathology associated with inflammatory perios-
titis [30, 62–64].
M. leprae ancient DNA (aDNA) was first detected in skeletal remains with typical leprosy 
paleopathology soon after the introduction of PCR [23]. Subsequently, many further paleo-
pathological cases of leprosy were confirmed by M. leprae aDNA from across Europe and the 
Middle East [24–27, 30, 49–51, 64–69]. Specific M. leprae short DNA sequences were targeted as 
ancient DNA (aDNA) becomes highly fragmented over time [70]. M. leprae aDNA amplifica-
tion has confirmed leprosy and enabled genotyping of isolates from Europe, Byzantine Turkey 
and Roman Egypt (Table 1). As additional methodologies were developed, different M. leprae 
strains were distinguished by microsatellite analysis based on aDNA repetitive sequences [27, 
71] and now whole M. leprae genomes have been obtained from historical human skeletons 
[46, 53]. The results of aDNA amplification studies, WGS and lipid biomarker detection are 
summarised in Table 1.
3.2. The potential of lipid biomarkers
The detection of M. leprae in historical leprosy cases is assisted by the M. leprae cell enve-
lope, which is composed of unusual lipids some of which can be used as specific biomarkers 
(Figures 1–3). The mycolic acids of M. leprae are restricted to homologous α- and ketomyco-
lates [79, 80], whose major components are shown in Figure 1.
Characteristic mycocerosic acids are components of both phthiocerol dimycocerosate waxes 
(PDIMs) (Figure 2) [81–83] and so-called phenolic glycolipids (PGLs) (Figure 3) [82–85]. 
M. leprae mycocerosates unusually include major amounts of a C
34
 component, accompanied 
by small proportions of a C
33
 acid (Figure 2). M. haemophilum produces a PGL with the same 
two internal sugars (3-O-Me-rhamnose and 2,3-di-O-Me-rhamnose), but in reversed order 
and with different linkages (Figure 3). Besra et al. [13] concluded that this mycocerosate pro-
file was essentially the same, thereby revealing a close phylogenetic link between M. leprae 
and M. haemophilum for the first time.
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Century (CE); location: 
cases
M. leprae M. leprae 
genotype
Notes Publications
DNA Lipids
1st; Israel, Akeldema, 
Himmon valley: SC1
+ Matheson et al. [69]
1st–4th; Uzbekistan 
Devkesken 6: 5b
+ + 3L Taylor et al. [27]
4th; Egypt, Dakhleh 
Oasis, Kellis 2: B116 and 
7 other samples
+ 3K/L/M (B116) Donoghue et al. [72]; 
Monot et al. [26]
4th–7th; Israel, 
Jerusalem: HZ
+ Spigelman and 
Donoghue [67]
5th–6th; United 
Kingdom, Great 
Chesterfield: GC96
+ + 3I-1 (variant) MTB – Inskip et al. [73]
6th–7th; Israel, 
monastery on River 
Jordan: AR
+ Rafi et al. [23]
6th–8th; Italy, Morrione: 
T68, T108
1/2 + (T108) Donoghue et al. [30]
7th; Hungary, Szeged-
Kiskundorozsma-
Daruhalom dűlő II: 
KD271, KD517, KD518
3/3+ KD517+ 3K (KD271) KD517 
lipids+ and 
MTB+
Minnikin et al. 
[29]; Lee et al. [28]; 
Donoghue et al. [30]
7th; Italy, Vicenne: T18, 
T31, T144
1/3+ (T18) 2/2+ (T18, 
T144)
DNA-
lipids+ 
(T144)
Donoghue et al. [30]
7th–8th; Hungary, 
Szentes-Kistőke: SK11
+ Donoghue et al. [30]
7th–9th; Hungary, 
Bélmegyer-Csömöki 
domb: 22
+ + MTB lipid+ Donoghue et al. [30]; 
Molnár et al. [74]
7th–9th; Hungary, 
Szarvas Grexa, 
Téglagyár: SG-38
+ + Minnikin et al. [29]; 
Donoghue et al. [30]
8th–9th; Turkey, 
Kovuklukaya: 9/1, 11/2, 
20/1, 24/1
3/4+ (11/2−) 1/3+ (24/1+) 3K (20/1) Minnikin et al. [29]; 
Donoghue et al. [30]
8th–9th; Croatia, 
Radasinovci: 2A, 3A
+ Watson et al. [49]
8th–9th; Austria, 
Zwölfaxing: 70, 88
2/2+ MTB DNA+ 
(88)
Donoghue et al. [30]
9th–10th; Czech 
Republic, Prušánky: 188
+ 3M Donoghue et al. [30]
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Century (CE); location: 
cases
M. leprae M. leprae 
genotype
Notes Publications
DNA Lipids
10th; Hungary, 
Hajdúdorog-Gyúlás: 
HG-56
+ + Minnikin et al. [29]; 
Donoghue et al. [30]
10th; Hungary, 
Sárrétudvari-Hízóföld: 
S237
+ Palate+ 
Toe−
Haas et al. [65]
10th–11th; UK, Norwich: 
11287, 11503, 11784
+ 3 Watson et al. [49]
10th–11th; Hungary, 
Püspökladány-
Eperjesvölgy 11, 222, 
429, 503
+ + (503) 3K (222)
3M (503)
222 and 503 
MTB+
Donoghue et al. [30]
10th–12th; UK, Wharram 
Percy: G708
+ 3 Taylor and Donoghue 
[71]
11th; Sweden, Björned: 
A4
+ + MTB+ Donoghue et al. [72]; 
Minnikin et al. [29]
10th–12th; Sweden, 
Sigtuna: 10, 32H, 3077, 
3092V, 3093F, 3159Hsin, 
3320V, 3401H, F13320, 
S10V3
7/10+ 2F (3092 and 3077)
3I (3093)
WGS Economou et al. [50, 
51]; Schuenemann 
et al. [46]
11th; Hungary, Felgyő, 
Kettőshalmi-dűlő: 2467, 
3658
1/2+ 3658+ Donoghue et al. [30]
11th; Hungary, 
Lászlófalva-Szentkirály: 
79
+ MTB+ Donoghue et al. [30]
11th–12th; UK, Orkney: 
CC4
+ Taylor et al. [66]
9th–13th; UK, 
Winchester: Sk2, Sk7, 
Sk19
Sk8, Sk14, Sk27
Sk18
+ + 3I-1
2F
WGS
Sk18 
(weak)
Schuenemann et al. 
[46];
Taylor et al. [21]
Roffey et al. 2017 [75]
11th–14th; Denmark, 
Refshale:2, 16, 26, 32, 36
1/5+ + 2F (Refshale16) Refshale 
16+
Schuenemann et al. 
[46]
12th; Spain, Seville: A43, 
A120
+ Montiel et al. [76]
12th; Czech Republic, 
Žatec: AO9611, AO9731
+ Likovsky et al. [77]
12th–14th; Poland, Suraz: 
A1
+ Donoghue et al. [70]; 
Witas et al. [78]
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The lipid composition of ‘M. lepromatosis’ remains to be determined, but limited information 
is available for M. haemophilum. In addition to α- and ketomycolates, M. haemophilum appears 
to have methoxymycolates, on thin-layer chromatography of extracts [86], but in a previous 
study, the patterns were unclear with material being degraded by acid methanolysis [87]. A 
gas chromatographic profile of M. haemophilum fatty acids [86] displayed an essentially typi-
cal mycobacterial profile, including tuberculostearic acid. The analysis was not extended to 
search for the unusual mycocerosic acids found previously in M. haemophilum (Figure 2) [13]. 
The only novel component was an incompletely characterised monounsaturated 2-methyl-
branched C
25
 fatty acid and an enhanced proportion of C
22
 docosanoic acid was noted as being 
Figure 1. Mycolic acids of M. leprae. The main C
78
 α-mycolate and C
83
 ketomycolate are shown; additional homologous 
components are also present.
Century (CE); location: 
cases
M. leprae M. leprae 
genotype
Notes Publications
DNA Lipids
13th–14th; Denmark, 
Odense: Jorgen 625, 1020
1/2+ + 3I (Jorgen 625) Jorgen 625+ Schuenemann et al. 
[46]
13th–16th; UK, Ipswich, 
Blackfriars: 1914
+ 3I* (variant) Taylor et al. [25, 27]; 
Taylor and Donoghue 
[71]
13th–16th; Denmark, 
Odense: G483
+ 3I/J Watson et al. [49]
15th; Hungary, 
Szombathely: 10
+ + Donoghue et al. [72]; 
Minnikin et al. [29]
15th–18th; Germany, 
Rain/Lech: R1788, R2208
2/2+ Haas et al. [65]
18th–20th; Japan, 
Aomori: SK26
+ 1 Suzuki et al. [52]
Cases are listed in a chronological order.
Table 1. Detection of ancient leprosy using aDNA and lipid biomarkers.
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similar to that found in M. leprae in a previous study [88]. However, an analysis of three 
M. leprae isolates did not record unusually enhanced proportions of docosanoic acid [80], 
nor did an additional analysis of M. haemophilum fatty acids [89]. It is interesting to compare 
the profile of uncharacterised fatty acids from M. haemophilum in an older study [87] with the 
more recent study [86]. An unusual large peak, labelled 19A, in the first analysis [87] could 
possibly correspond to the minor branched C
25
 acid in the later analysis [86]. This unusual C
25
 
acid is a potentially valuable biomarker for M. haemophilum so its structure and cellular loca-
tion should be investigated.
The biomarker potential of M. leprae lipids has been harnessed by fluorescence high perfor-
mance liquid chromatography (HPLC) of pyrenebutyric acid (PBA) esters of mycolic acid 
pentafluorobenzyl (PFB) esters [90] and negative-ion chemical-ionisation gas-chromatogra-
phy mass-spectrometry (NI-CI GC-MS) of mycocerosate PFB esters [91, 92]. Mycolate HPLC 
is exemplified in Figure 4 for standard M. leprae and an extract of a skeleton (Sk2) from a 
mediaeval leprosy hospital near Winchester, UK [21]. Fluorescent mycolate derivatives are 
recognised by reverse-phase HPLC (Figure 4A), collected and analysed by normal phase 
HPLC to separate the α- and ketomycolate classes (Figure 4B). Reverse-phase HPLC provides 
the size and overall composition of the α-mycolates (Figure 4C) and ketomycolates (Figure 4D) 
for comparison with standard M. leprae.
Figure 2. Phthiocerol dimycocerosates (PDIMs) of M. leprae. The C
33
 and C
34
 mycocerosates are diagnostic components 
for M. leprae and M. haemophilum, but C
29
, C
30
 and C
32
 acids are shared with members of the M. tuberculosis complex [13, 
81, 82].
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Selected ion monitoring NI-CI GC-MS analyses of mycocerosate PFB esters from Winchester 
skeleton Sk2 [21] and standard M. leprae are shown in Figure 5. There is good correspondence 
between the Sk2 extract and the standard; the Sk2 profile is unpublished work (O.Y-C. Lee, 
H.H.T. Wu, G.M. Taylor, K. Tucker, R. Butler, S. Roffey, P. Marter, D.E. Minnikin, G.S. Besra, 
G.R. Stewart, manuscript in preparation). In summary (Table 1), aDNA analysis with occa-
sional lipid biomarker support has been successful in characterising ancient leprosy [21, 27, 29].
3.3. Distribution and phylogeny of ancient leprosy
Further, aDNA studies based on M. leprae sub-genotypes have given valuable information 
about the distribution of the disease in different human populations in the past [26]. The 
earliest known case of leprosy recognised by both skeletal paleopathology and aDNA, was 
from the early first millennium CE from the Ustyurt Plateau, Uzbekistan [93], with radiocar-
bon dating that suggests a date between the first and third centuries CE [94]. The M. leprae 
Figure 3. Phenolic glycolipids of M. leprae and M. haemophilum. The common phenolphthiocerol unit is attached to 
distinctive trisaccharides that share particular diagnostic sugars, 3-O-Me-rhamnose and 2,3-di-O-Me-rhamnose [13].
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aDNA from this location was found to be of sub-genotype 3L [27] and the variable number 
tandem repeat analysis identified a unique aDNA profile [71]. Sub-genotyping has revealed 
that in historical Europe, there are clear differences between the leprosy found in human 
Figure 4. Mycolic acid profiles of Winchester skeleton Sk2. (A) Total mycolates, reverse phase HPLC; (B) collected total 
mycolates (MAs), normal phase; (C) collected α-mycolates, reverse phase; (D) Collected ketomycolates, reverse phase [21].
The Distribution and Origins of Ancient Leprosy
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populations from central and southern Europe, compared with northwest Europe (Table 1 
and Figure 6). In Scandinavia and the British Isles, there are examples of M. leprae genotypes 
2F and 3I [21, 46, 53, 75]. In historical northwest Europe, 3I-1 sub-genotypes were common, 
but in Hungary, Byzantine Turkey and the Czech Republic, sub-genotypes 3K and 3M were 
found [30]. It is believed that these differences reflect past human population movements. In 
northwest Europe, people travelled from Siberia and the Arctic, whereas central Europe was 
colonised by successive migrations from central Asia via ancient routes, such as the so-called 
Silk Road. WGS of the 3K subtype shows that it belongs to the earliest lineage of extant M. leprae, 
now termed branch 0 [46], and therefore carries characteristics of the most recent common 
ancestor (MRCA), not found in other groups. The distribution of the various European sub-
genotypes is summarised in Figure 6 and their phylogenetic relationship in Figure 7. It would 
be informative to have more data points for the Mediterranean basin and major countries, 
such as Spain, France and Germany.
Figure 5. Mycocerosic acid profiles of Winchester skeleton Sk2. Selected ion monitoring NI-CI GC-MS of mycocerosic 
acid pentafluorobenzyl ester from A, Sk2 and B, M. leprae standard.
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3.4. Co-infection of leprosy and tuberculosis
Leprosy was a significant problem in Scandinavia until a century ago, leading to the identifi-
cation of the leprosy bacillus by Hansen in 1871 [95], although publication was delayed due 
to the inevitable unsuccessful attempts at culture. In Central Europe, however, leprosy was 
prevalent in the first millennium CE, but a subsequent decline appeared to coincide with the 
upsurge of tuberculosis. Support for a period of overlap between leprosy and tuberculosis 
has been provided by a number of clear archaeological examples of dual infection, from first 
century AD Israel, fourth to fifth century Roman Egypt, seventh to eleventh century Hungary, 
eighth to ninth century Austria to tenth to thirteenth century Sweden [30, 72]. In one particu-
lar case, it was possible to use quantitative lipid biomarker analysis to estimate the relative 
amount of leprosy and tuberculosis infection [28–30]. Mathematical modelling to explore the 
epidemiological consequences of dual infection concluded that the disappearance of leprosy 
could indeed be explained by M. leprae/M. tuberculosis co-infections [96]. This may explain the 
present absence of indigenous human leprosy in Europe. Currently characterised M. leprae/M. 
tuberculosis co-infections are summarised in Table 2.
Figure 6. Geographical distribution of ancient leprosy sub-genotypes in the European area. Three type 3 strains are 
included where sub-typing was not determined.
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Figure 7. A phylogeny of selected M. leprae strains. The phylogeny was derived from an alignment of genomic SNPs [46]; 
ancient strains are denoted in bold. Phylogenies were generated in MEGA7 [105], using Maximum Likelihood methods. 
Phylogenies based on Neighbour Joining methods generated similar dendrograms. The scale represents the number of 
substitutions per site. Bootstrap values were determined from 500 replicates. ‘M. lepromatosis’ was used as an out-group 
(not shown). Subtypes are indicated in brackets.
Authors Year Region Century 
(CE)
Methods and comments
Nuorala et al. [97] 2004 Sweden 10th–13th PCR: ML RLEP 129/99 bp; MTB 123 bp/92 bp. Nested 
products sequenced
Donoghue et al. [72] 2005 Egypt
Hungary
Israel
Sweden
4th–5th
10th–16th
1st
10th–13th
PCR: ML RLEP 129/99 bp; MTB 123 bp/92 bp
Matheson et al. [69] 2009 Israel 1st PCR: ML RLEP 129/99 bp; MTB IS6110 123/92 bp
Minnikin et al. [29] 2011 Hungary 7th PCR: Not re-tested; Lipids: mycolates and mycocerosates 
indicate relative disease load for Kiskundorozsma-
Daruhalom dűlő II Grave KD517
Minnikin et al. [29] 2011 Hungary 15th PCR: Not re-tested; Lipids: MTB methoxymycolates and 
ML ketomycolates for Szombathely Grave 6
Molnár et al. [74] 2015 Hungary 7th–9th PCR: MTB IS6110 123/92 bp; IS1081 113 bp; ML 
not tested; Lipids: mycolates, mycolipenate and 
mycocerosates for Bélmegyer-Csömöki domb Grave 22
Donoghue et al. [30] 2015 Central and 
Eastern 
Europe
Various
6th–11th
PCR: ML RLEP 129/99 bp; 111 bp; 80 bp and probe; 
RepLep 66 bp and probe; SNP typing indicates migratory 
patterns into Europe. Coinfections suggest role of MTB in 
decline of European leprosy
Cases are listed according to year of study.
Table 2. aDNA and lipid biomarker detection of ancient M. leprae and M. tuberculosis complex co-infections.
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4. Origins and evolution of leprosy
4.1. Genomics of modern leprosy
Whole genome sequencing has revealed large numbers of pseudogenes in both M. leprae 
and ‘M. lepromatosis’ [7, 8, 98–100]. These genomic studies revealed that both M. leprae and 
‘M. lepromatosis’ have undergone a reductive evolution in which extensive recombination 
events have occurred between dispersed repetitive sequences, leading to less than half of 
their genomes containing functional genes. In a preliminary study [7], it was indicated that 
the genome of ‘M. lepromatosis’ (~3.22 Mb) was 1.6% smaller than that (~3.27 Mb) of M. leprae 
[98, 99]. A comprehensive parallel study gave a similar genome size of ~3.21 for ‘M. lepromato-
sis’ [8]. Functional comparisons revealed that whereas M. leprae has a defective heme pathway, 
‘M. lepromatosis’ lacked several genes needed for amino acid synthesis [8]. It is apparent that 
‘M. lepromatosis’ is the closest known mycobacterial taxon to the established species of M. lep-
rae. Phylogenetic analysis indicates that ‘M. lepromatosis’ and M. leprae diverged from a most 
recent common ancestor (MRCA) about 13.9 million years ago [8].
4.2. Evolutionary origins of leprosy bacilli
The deep origins of mycobacterial disease remain to be clearly defined [3, 47, 98, 99]. In con-
trast to tuberculosis, which appears to stretch back hundreds of thousands of years [57, 58], the 
earliest manifestations of human leprosy are found in skeletal remains only about 4000 years 
old [101]. However, the older participation of animal hosts cannot be ruled out, as it is increas-
ingly evident that Pleistocene megafauna may have had a major involvement in tuberculosis 
evolution [58]. A possible ancestral organism to the organisms that cause leprosy may have 
been more like modern M. haemophilum, an emerging pathogen with a variety of possible nat-
ural reservoirs. The first significant link identified between M. leprae and M. haemophilum was 
established a quarter of a century ago in a study of the so-called ‘phenolic glycolipids’ (PGLs) 
[13]. As shown in Figure 3, the similarity in the oligosaccharide composition of the PGLs was 
striking and the mycocerosate profile (Figure 2) almost identical. This early key observation 
was subsequently reinforced by taxonomic studies that showed a close association of M. leprae 
and M. haemophilum [14, 15, 102]. Again, in studies comparing M. leprae and ‘M. lepromatosis’, 
M. haemophilum was the nearest neighbour [8, 39], as illustrated in Figure 8. The recent deter-
mination of a full genome (~4.23 Mb) for M. haemophilum confirmed the close link [16], as 
shown in Figure 8. M. haemophilum is consistently placed outside of the M. leprae/M. leproma-
tosis group but between M. leprae and other mycobacteria such as the M. tuberculosis complex. 
It was suggested that the reductive evolution of M. leprae and ‘M. lepromatosis’ was not shared 
with the most recent common ancestor but started after the divergence of M. haemophilum 
from both taxa [16]. The relatedness of M. haemophilum, M. leprae, ‘M. lepromatosis’ and related 
taxa is shown in Figure 8.
4.3. Animal and environmental sources of leprosy ancestors
To assess the involvement of ancient relatives of M. haemophilum in the evolution of leprosy 
bacilli, it is necessary to consider the ecological, environmental and animal host preferences of 
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this taxon. M. haemophilum is slow growing, requires iron supplementation and prefers a low 
growth temperature of 30°C. The first description of M. haemophilum was as a pathogen caus-
ing skin infections, particularly not only in immunocompromised patients [106, 107], but also 
in healthy children [108]. In a range of children, a variety of other clinical manifestations were 
encountered [15]. In two instances, M. haemophilum infections mimicked the appearance of 
leprosy [109, 110] and a co-infection of M. leprae and M. haemophilum has been reported [111]. 
Also, animal infections are common, with zebra fish (Danio rerio) being particularly suscep-
tible [15]. More recently, a heavily infected leatherback sea turtle (Dermochelys coriacea) was 
found [112]. Infection of a haemophiliac with M. haemophilum was linked to contact with raw 
shrimp [113]. This suggests that M. haemophilum can move freely in a variety of environments, 
but it does not give a clear indication whether there is a particular zoonotic host in which the 
evolution of M. haemophilum may have occurred.
As noted previously, both M. leprae and ‘M. lepromatosis’ can cause disease in squirrels [11, 12, 
43, 44]. The presence of leprosy in armadillos is long established [9, 10, 114, 115] and, indeed, the 
armadillo was a prime source of material for early studies of the leprosy bacillus [79–81, 
83, 84]. It is apparent that infected armadillos can spread leprosy to the human population [9, 10]. 
However, the leprosy introduced into the Americas by human migration was passed on to 
indigenous armadillos [46] so they can be eliminated as an environmental evolutionary source. 
The involvement of squirrels in the UK is more intriguing as it is difficult to  envisage how 
Figure 8. A phylogeny of M. leprae strains and other mycobacterial species. Genomic sequence coding for DnaN [103] 
from illustrative mycobacterial species was aligned with Clustal Omega [104] and their phylogeny inferred with MEGA7 
[105] using the Maximum Likelihood methods and the Hasegawa-Kishino-Yano model with possible invariant sites. 
Phylogenies consistent with this interpretation were obtained with Neighbour-joining methods and when concatenated 
amino acid sequence of conserved proteins was used in the alignment. Bootstrap values are derived from 500 replicates.
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the diseases can have been contracted from human sources. A direct evolutionary  pathway 
from ancient squirrel-like animals to humans is unlikely, but it is possible that squirrels are 
 representative of other animals that may have acted as environmental reservoirs. In the case 
of ‘M. lepromatosis’, a geographical association between patients and Mexican field rats (Rattus 
rattus) suggests a possible environmental reservoir [8].
4.4. Animal diseases resembling leprosy
Cases of tuberculoid nodular thelitis in both cattle [116] and goats [117] appear to be caused 
by uncultivable acid-fast species related to M. leprae and ‘M. lepromatosis’. However, the inter-
relationships between these agents, infecting cattle and goats, need to be defined more pre-
cisely before the disease can be considered as a true variety of leprosy. A complex scenario 
is emerging regarding the status of infections categorised as ‘feline leprosy’ [118–121]. After 
many early reports of diverse manifestations of cat leprosy, a definitive study clarified the 
scene [122]. It was apparent that the rat leprosy bacillus, M. lepraemurium, made a contribu-
tion to disease, but the influence of a novel uncultivable Mycobacterium, whose closest rela-
tive was M. malmoense, was noted. In a follow-up study [123], it was observed that younger 
cats were susceptible to M. lepraemurium, but more mature felines typically harboured the 
novel uncultivable agent. In an interesting development, PCR amplification of 16S rRNA 
sequences, from the uncultured feline agent AJ294740-6, showed that the greatest nucleotide 
identity was shared with M. leprae and M. haemophilum, as well as M. malmoense; indeed a 
specific additional nucleotide correlated with only with M. leprae [124]. This particular taxon, 
expressed in cases from eastern Australia, New Zealand and possibly Canada, has been pro-
visionally labelled ‘M. lepraefelis’ [121]. Three North American feline infections appeared 
to be caused by another uncultivable agent with close 16S rRNA relatedness to M. leprae 
and more distant affinity to M. haemophilum, among other species [125]. Initially labelled 
‘M. visibilis’, but more properly ‘M. visibile’, this taxon remains uncharacterised and unfor-
tunately unavailable for further study [120]. In a limited area of southeast Australia, studies 
of feline leprosy have revealed the presence of M. lepraemurium and an uncultivable novel 
agent, labelled ‘M. tarwinense’. This agent was indicated to be a fastidious member of the 
M. simiae complex [120, 126] so it does not appear to have a direct relationship with M. leprae 
or ‘M. lepromatosis’.
4.5. Overall interrelationships of leprosy affiliates
The precise interrelationships between all the bacterial taxa causing leprosy-like diseases 
require further study. It is clear that M. leprae or ‘M. lepromatosis’ cause human leprosy and the 
same agents can routinely infect armadillos and squirrels. The apparent affinities of the feline 
leprosy taxon, labelled ‘M. lepraefelis’, with M. leprae and M. haemophilum must be explored. 
The agents causing tuberculoid nodular thelitis in cattle and goats appear to have an affinity 
with established leprosy bacilli and this should be thoroughly investigated. In view of pres-
ent uncertainties, it is premature to consider any concept of an M. leprae complex, as has been 
discussed [6, 8, 118, 127].
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The possible origins and interrelationships of all agents causing leprosy-like disease are sum-
marised in Figure 9. The phylogeny of M. haemophilum with M. leprae and ‘M. lepromatosis’ 
indicates a deep common ancestor for all three taxa [16]; this ancestor is provisionally labelled 
Figure 9. Origins and interrelationships of agents causing leprosy-like disease. Proposed relationships requiring 
further study are indicated (?). ‘PROTOLEP’ represents a prototype taxon with the specific type of outer membrane 
lipids expressed in M. haemophilum, M. leprae and possibly ‘M. lepromatosis’. M. simiae complex (1) represents species 
(M. florentinum, M. interjectum, M. sherrissii, M. triplex) apparently expressing genes for PDIM synthesis; M. simiae 
complex (2) includes the remaining species [128].
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‘PROTOLEP’ in Figure 9. This hypothetical taxon is considered to incorporate characteristic 
cell envelope lipids, such as the C
34
 mycocerosates found in M. leprae and M. haemophilum 
(Figure 2). Sensitive lipid biomarker analysis has the potential to help identify the uncultiva-
ble agents causing feline leprosy (‘M. lepraefelis’, ‘M. visibile’) and tuberculoid nodular thelitis 
in cattle and goats (Figure 9). It is an open question whether these agents have any affinity 
with M. leprae, ‘M. lepromatosis’ or M. haemophilum, but it seems likely that the feline cases that 
are associated with both M. lepraemurium and ‘M. tarwinense’ [119, 120, 126] (Figure 9) are 
distinct. ‘M. tarwinense’ appears to be an affiliate of the M. simiae complex, which appeared 
to have little phylogeny with M. leprae and related taxa until detailed genomic characterisa-
tion of nontuberculous mycobacteria indicated that particular M. simiae complex members 
(M. florentinum, M. interjectum, M. sherrissii, M. triplex) apparently have genes for PDIM syn-
thesis (Figure 9) [128]. It would be of interest to discover if there is any similarity between 
the proven PDIMs of M. leprae and those suggested to be expressed by these members of the 
M. simiae complex.
5. Conclusions
An understanding of the origins and spread of leprosy depends on establishing detailed 
knowledge of the ancient genotypes and their correlation with modern disease. The over-
all scenario has been expanded by the recent characterisation of the distinct modern clade, 
currently labelled ‘M. lepromatosis’. The availability of a full genome for ‘M. lepromatosis’ is 
allowing specific probes to be developed to search for ancient expression of this biotype. 
Ongoing research is demonstrating that subtle lipid biomarker differences may be of value 
in distinguishing ‘M. lepromatosis’ from M. leprae. The overall picture for the global devel-
opment of leprosy suggests that the ancient disease evolved into a number of recognisable 
clades in Africa/Eurasia. It is clear that leprosy was introduced into the Americas by human 
migration, and the disease was passed on to indigenous armadillos. The deeper origins of 
leprosy appear to be inextricably linked to relatives of the environmental taxon M. haemophi-
lum. Diseases in cats, cattle and goats, with affiliations and resemblances to leprosy, require 
detailed investigation.
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